Alpha-1 antitrypsin (A1-PI) treatment slows emphysema progression independent of baseline FEV1
According to MHRA product information, constipation is very common (affecting more than 1 in 10 people) with higher doses used for weight management (Wegovy, Saxenda), while it is common (affecting up to 1 in 10 people) with doses typically used for diabetes (Ozempic, Victoza)
Many men with clinically normal testosterone still report low libido, which points to something else going on upstream
doi: 10.3945/ajcn.26842 [DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article
This regulatory intervention correlated with measurably lower population-wide exposure levels, demonstrating the effectiveness of systematic emission control policies (142)
The authors concluded that while the combination showed limited effectiveness in the overall population, it might offer potential benefits for individuals with particular baseline features [76]